Showing results (431-440 of 919) with videos related to

Sort By:
Pageof 92
AIDS Research and Human Retroviruses|March 21, 2006
Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAARTAdriana Weinberg, Andrew A Wiznia, Bonnie J Lafleur, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 28, 1979
Radiocolloid imaging in primary liver cancer and amoebic liver abscess. Accuracy of differential diagnosis and extent of inter-observer variabilityM C Kew, H I Osler, W G McCann, et al.
Cureus|November 7, 2022
A Systematic Review and Meta-Analysis Comparing Burn Healing Outcomes Between Silver Sulfadiazine and Aloe veraNicole J Levin, Young Erben, Yupeng Li, et al.
Metabolism: Clinical and Experimental|October 1, 1980
Cortisol production in obesityG W Strain, B Zumoff, J J Strain, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 4, 2006
Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptorC Smulski, V Labovsky, G Levy, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1990
Splenic thrombopoiesis after bone marrow ablation with radiostrontium: a murine modelE Davis, L Corash, G Baker, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2002
Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell linesJeffry J Leary, Robert Wittrock, Robert T Sarisky, et al.
Biochemical and Biophysical Research Communications|October 13, 2007
Mapping of the protein-binding interface between splicing factors SF3b155 and p14 of Trypanosoma cruziM Lara Avila, Natalia Bercovich, Gastón Westergaard, et al.
Viral Immunology|January 1, 1996
Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccineA R Hayward, K Buda, M Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung diseaseB A Brown, D E Griffith, W Girard, et al.
Pageof 92